Christopher James Roberson is a Baltimore, Maryland based nurse practitioner who is specialized as Gerontology nurse. His current practice location is 827 Linden Ave Ste B, Baltimore. Patients can reach him at 410-328-5487 or can fax him at 410-328-4430. Christopher James Roberson is CRNP with specialization in Gerontology and his NPI number (Unique professional ID assigned by NPPES) is 1184064941. Christopher James Roberson is specially trained to treat the complex physical and mental health needs of older adults. He have the right to administer medications, order and assess diagnostic tests, and design and implement comprehensive treatment plans for his patients. Adult Gerontology Nurse Practitioner (AGNP) day-to-day responsibilities include helping older patients with daily tasks like eating, bathing, dressing, and walking, administering medications, monitoring vital signs, cooperating with physicians, other advanced nurse practitioners, and registered nurses.
Complete Profile:
Christopher James Roberson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1184064941
NPI Enumeration Date:
26 Jun, 2013
NPI Last Update On:
14 May, 2019
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Christopher James Roberson 877 1/2 W Lombard St, Baltimore, Maryland
Zip:
21201-1061
Phone Number:
443-857-7247
Patients can reach Christopher James Roberson at 827 Linden Ave Ste B, Baltimore, Maryland or can call to book an appointment on 410-328-5487.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.